arrow
Y

Yoshinori Kagawa

Osaka International Cancer Institute
H指数:35
被引数:4,645

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early tumor shrinkage during first-line immune checkpoint inhibitor–based chemotherapy is associated with progression-free survival in measurable unresectable gastric cancer

一线免疫检查点抑制剂为基础化疗期间早期肿瘤缩小与可测量不可切除胃癌的无进展生存期相关

2026-09-180
OAAI
Longitudinal ctDNA profiling to guide anti-EGFR rechallenge in metastatic colorectal cancer: a prospective single-arm phase II trial

纵向ctDNA分析指导抗EGFR再挑战治疗在转移性结直肠癌中的应用:一项前瞻性单臂II期临床试验

2026-09-090
OAAI
Immunotherapy-Facilitated Conversion Surgery for Biliary Tract Cancer: A Case Series of Long-Term Survivors Following Durvalumab Combined With Gemcitabine and Cisplatin

免疫疗法促进的转化手术用于胆道癌:度伐利尤单抗联合吉西他滨和顺铂治疗后长期生存者的病例系列

2026-06-110
PRE
Prevalence of MSI-H/dMMR Colorectal Cancer in Japan: Data From the Clinical Study Group of the University of Osaka-Colorectal Registry

日本微卫星不稳定性高/错配修复缺陷型结直肠癌的患病率:来自大阪大学结直肠登记临床研究组的数据

2026-05-240
OAAI
Clinical Outcomes of First-Line Immune Checkpoint Inhibitor–Based Therapy for Postoperative Recurrence After Adjuvant Nivolumab in Esophageal Cancer

术后辅助纳武利尤单抗治疗后食管癌复发患者一线免疫检查点抑制剂为基础治疗的临床结局

2026-05-200
PRE
Correction: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

更正:辅助纳武利尤单抗治疗切除后局部晚期食管癌术后复发的风险分层:一项真实世界研究

2026-05-040
PRE
Learning curve for the abdominal procedure in total robot-assisted minimally invasive esophagectomy with simultaneous cervical approach: an initial experience

在同时采用颈部入路的全机器人辅助微创食管切除术中的腹部手术学习曲线:初步经验

2026-05-011
PRE
Phase II study of maintenance trifluridine/tipiracil (TAS-102) plus bevacizumab after induction chemotherapy in metastatic colorectal cancer

二线维持治疗研究:在诱导化疗后对转移性结直肠癌患者使用曲氟尿苷替匹嘧啶(TAS-102)联合贝伐珠单抗

2026-05-010
OA
ASO Visual Abstract: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

ASO视觉摘要:辅助尼洛替尼治疗切除的局部晚期食管癌术后复发的风险分层:一项真实世界研究

2026-04-220
PRE
Hybrid robot-assisted surgery versus conventional fully robotic surgery for colon cancer: study protocol for a multicenter, parallel-group, single-blind randomized controlled superiority trial

结肠癌的混合机器人辅助手术与常规全机器人手术的比较:一项多中心、平行组、单盲随机对照优效性试验研究方案

2026-04-220
PRE
Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

术后辅助纳武利尤单抗治疗局部晚期食管癌切除术后复发的风险分层:一项真实世界研究

2026-04-140
PRE
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum

直肠癌症患者接受根治性手术后的分子残留病灶与复发:前瞻性队列研究:勘误

2026-04-090
PRE
Zolbetuximab-based chemotherapy in CLDN18.2-positive gastric cancer: real-world tumor response and early albumin kinetics

Zolbetuximab联合化疗在CLDN18.2阳性胃癌中的应用:真实世界肿瘤反应及早期白蛋白动力学

2026-02-010
PRE
A single-center retrospective study of conversion surgery in stage IV gastric cancer: association with immune checkpoint inhibitor-based chemotherapy

单中心回顾性研究:IV期胃癌转化手术与基于免疫检查点抑制剂化疗的相关性

2026-01-011
PRE
The SPECTACLE Study: A Multicenter, Prospective, Single-Arm Trial Evaluating Quantitative Blood Flow Assessment Using SPY-QP Software in Minimally Invasive Rectal Cancer Surgery

SPECTACLE研究:一项多中心、前瞻性、单臂试验,评估在微创直肠癌手术中使用SPY-QP软件进行定量血流评估。

2025-12-230
OAAI